Alain Pitton/NurPhoto via Getty Images
© 2024 Blaze Media LLC. All rights reserved.
Anxiety, Tourette sufferers will soon be able to legally smoke weed in Pennsylvania
July 12, 2019
The state has added to its list of qualifying conditions for medical marijuana
The Pennsylvania Department of Health has announced that anxiety disorders and Tourette syndrome will soon be added to the list of qualifying conditions for patients to obtain certifications to use medical marijuana.
What are the details?
PDHS Secretary Dr. Rachel Levine said in a press release Thursday, "After careful review of the medical literature available out these conditions, I have to decided to approve this recommendation," adding, "I do not take this decision lightly, and do have recommendation for physicians, dispensary pharmacists and patients in terms of the use of medical marijuana to treat these conditions."
Levine also noted that "medical marijuana is not recommended to treat children and adolescents with anxiety disorders, as their brains are still developing." The press release did not say, however, whether there were any age restrictions under the expanded rule, which goes into effect July 20.
Pennsylvania legalized medical marijuana in 2016, according to
The Hill, which reported that there are currently 111,000 patients actively participating in the state's program. The PDHS says there are more than 1,100 physicians who have been approved under the program.
Anxiety disorder and tourettes syndrome now approved conditions for Pennsylvania medical marijuanawww.youtube.com
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
Breck Dumas
Breck is a former staff writer for Blaze News. Prior to that, Breck served as a U.S. Senate aide, business magazine editor and radio talent. She holds a degree in business management from Mizzou, and an MBA from William Woods University.
more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.